- Solve real problems with our hands-on interface
- Progress from basic puts and calls to advanced strategies
Interactive Options Course
Posted October 30, 2023 at 11:30 am
Use the Securities Lending Dashboard to analyze short sale metrics for these and other stocks.
| Rank | Stock | Description |
| 1 | ABR | ARBOR REALTY TRUST INC |
| 2 | GME | GAMESTOP CORP-CLASS A |
| 3 | TH | TARGET HOSPITALITY CORP |
| 4 | LCID | LUCID GROUP INC |
| 5 | XPEV | XPENG INC – ADR |
| 6 | FLNG | FLEX LNG LTD |
| 7 | MARA | MARATHON DIGITAL HOLDINGS IN |
| 8 | PLUG | PLUG POWER INC |
| 9 | NKLA | NIKOLA CORP |
| 10 | BOH | BANK OF HAWAII CORP |
| Rank | ETF | Description |
| 1 | SQQQ | PROSHARES ULTRAPRO SHORT QQQ |
| 2 | KRE | SPDR S&P REGIONAL BANKING |
| 3 | VXX | IPATH SERIES B S&P 500 VIX |
| 4 | HYG | ISHARES IBOXX HIGH YLD CORP |
| 5 | ARKK | ARK INNOVATION ETF |
| 6 | DIA | SPDR DJIA TRUST |
| 7 | UVXY | PROSHARES ULTRA VIX ST FUTUR |
| 8 | XHB | SPDR S&P HOMEBUILDERS ETF |
| 9 | XBI | SPDR S&P BIOTECH ETF |
| 10 | IWO | ISHARES RUSSELL 2000 GROWTH |
| Rank | ETF | Description |
| 1 | ABVC | ABVC BIOPHARMA INC |
| 2 | INVO | INVO BIOSCIENCE INC |
| 3 | ASPA | ABRI SPAC I INC |
| 4 | INM | INMED PHARMACEUTICALS INC |
| 5 | FRBN | FORBION EUROPEAN ACQUISITI-A |
| 6 | BTAI | BIOXCEL THERAPEUTICS INC |
| 7 | SAVA | CASSAVA SCIENCES INC |
| 8 | LMDX | LUMIRADX LTD |
| 9 | ASTI | ASCENT SOLAR TECHNOLOGIES |
| 10 | APLM | APOLLOMICS INC |
| Rank | ETF | Description |
| 1 | UVXY | PROSHARES ULTRA VIX ST FUTUR |
| 2 | VXX | IPATH SERIES B S&P 500 VIX |
| 3 | UVIX | 2X LONG VIX FUTURES ETF |
| 4 | ARKK | ARK INNOVATION ETF |
| 5 | BITO | PROSHARES BITCOIN STRAT ETF |
| 6 | SOXS | DIREXION DAILY SEMI BEAR 3X |
| 7 | TBT | PROSHARES ULTRASHORT 20+Y TR |
| 8 | VIXY | PROSHARES VIX SHORT-TERM FUT |
| 9 | LABD | DRX DLY S&P BIOTECH BEAR 3X |
| 10 | XSHQ | INVESCO S&P SMALLCAP QUALITY |
| Rank | Stock | Description |
| 1 | WE | WEWORK INC-CL A |
| 2 | TPST | TEMPEST THERAPEUTICS INC |
| 3 | VFS | VINFAST AUTO LTD |
| 4 | SFWL | SHENGFENG DEVELOPMENT LTD-A |
| 5 | AWIN | AERWINS TECHNOLOGY INC |
| 6 | FRHC | FREEDOM HOLDING CORP/NV |
| 7 | BLTE | BELITE BIO INC – ADR |
| 8 | GDHG | GOLDEN HEAVEN GROUP HOLDINGS |
| 9 | NAAS | NAAS TECHNOLOGY INC-ADR |
| 10 | NVAX | NOVAVAX INC |
| Rank | ETF | Description |
| 1 | REMX | VANECK RARE EARTH/STRAT MET |
| 2 | CALF | PACER US SMALL CAP CASH COWS |
| 3 | UVIX | 2X LONG VIX FUTURES ETF |
| 4 | TUR | ISHARES MSCI TURKEY ETF |
| 5 | UVXY | PROSHARES ULTRA VIX ST FUTUR |
| 6 | URTY | PROSHARES ULTRAPRO RUSS2000 |
| 7 | HIBL | DIREXION DAILY S&P 500 HIGH |
| 8 | DAX | GLOBAL X DAX GERMANY ETF |
| 9 | PSCE | INVESCO S&P SMALLCAP ENERGY |
| 10 | EWI | ISHARES MSCI ITALY ETF |
The analysis in this material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IBKR to buy, sell or hold such investments. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Interactive Brokers, its affiliates, or its employees.
Any discussion or mention of an ETF is not to be construed as recommendation, promotion or solicitation. All investors should review and consider associated investment risks, charges and expenses of the investment company or fund prior to investing. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Day Trading can be extremely risky and may not be appropriate for individuals with limited resources, investment experience or low risk tolerance. Please review the Day Trading Risk Disclosure Statement before deciding whether Day Trading is appropriate for you.
Complex or Leveraged Exchange-Traded Products are complicated instruments that should only be used by sophisticated investors who fully understand the terms, investment strategy, and risks associated with the products. Learn more about the risks here: https://gdcdyn.interactivebrokers.com/Universal/servlet/Registration_v2.formSampleView?formdb=4155
Trading on margin is only for experienced investors with high risk tolerance. You may lose more than your initial investment. For additional information regarding margin loan rates, see ibkr.com/interest
Related Articles
Join The Conversation
For specific platform feedback and suggestions, please submit it directly to our team using these instructions.
If you have an account-specific question or concern, please reach out to Client Services.
We encourage you to look through our FAQs before posting. Your question may already be covered!